CXCL8 can increase the activities of NF-κB and AKT, increase expression of adhesion molecules ICAM-1, VCAM-1, and CD44, promote adhesion, migration, and invasion of GC cells, and is involved in the development of resistance to oxaliplatin (134). Here, ICAM1 is linked to gastric cancer.